1 Liver Institute Northwest and Elson S. Floyd College of Medicine, Washington State University, Seattle, Washington, USA.
2 Toronto Centre for Liver Disease, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
3 Real World Evidence, Syneos Health, Morrisville, North Carolina, USA.
4 Intercept Pharmaceuticals, Morristown, New Jersey, USA.
5 Department of Population Health Sciences, Duke University, Durham, North Carolina, USA.
6 Cambridge University Hospitals NHS Foundation Trust MRC Clinical Academic Research Partner, Academic Department of Medical Genetics, University of Cambridge, Cambridge, UK.
7 Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, UK.
8 National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
9 Department of Epidemiology and Biostatistics, Erasmus MC, Rotterdam, Netherlands.
10 IHPME University of Toronto, Toronto, Ontario, Canada.
11 Toronto Centre for Liver Disease and TGHRI, University Health Network, Toronto, Ontario, Canada.
12 Cambridge Liver Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
13 Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada.
14 University of California Davis, Sacramento, California, USA.
15 Flinders Medical Centre, Adelaide, South Australia, Australia.
16 University of Milano-Bicocca, Milano, Italy.
17 La Fe University Hospital, IISLaFe, Ciberehd, University of Valencia, Valencia, Spain.
18 Medical University of Warsaw, Warszawa, Poland.
19 Translational Medicine Group, Pomeranian Medical University, Szczecin, Poland.
20 Intercept Pharmaceuticals, London, UK.
21 Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.